Uptake of PMMA nanoparticles from the gastrointestinal tract after oral administration to rats: Modification of the body distribution after suspension in surfactant solutions and in oil vehicles

International Journal of Pharmaceutics

Volumn 176, Issue 2, 1999, Pages 209-224

  Araujo, L ^a   Sheppard, M ^a   Lobenberg R ^a   Kreuter, J ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Body distribution; Nanoparticles; Oil and surfactant coating; Peroral administration

Indexed keywords

ARACHIS OIL; CARBON 14; NANOPARTICLE; OLEIC ACID; POLOXAMINE 908; POLY(METHYL METHACRYLATE); UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; FEMALE; GASTROINTESTINAL TRACT; ISOTOPE LABELING; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUSPENSION;

EID: 0032912824     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00314-7     Document Type: Article

References (34)

1. Alpar H.O., Field W.N., Hyde R., Lewis D.A. The transport of microspheres from the gastrointestinal tract to inflammatory air pouches in the rat. J. Pharm. Pharmacol. 41:1989;194-196.
2. Aprahamian M., Michel C., Humbert W., Devissaguet J.P., Damgé C. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol. Cell. 61:1987;69-76.
3. Beck P.H., Kreuter J., Müller W.E.G., Shatton W. Improved peroral delivery of avarol with polybutylcyanoacrylate nanoparticles. Eur. J. Biopharm. 40:1994;134-137.
4. Damgé C., Michel C., Aprahamian M., Couvreur P. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carriers. Diabetes. 37:1988;246-251.
5. 14C] acrylate nanoparticles in healthy and chronically inflamed rabbit eyes. Int. J. Pharm. 54:1989;149-153.
6. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Controlled Rel. 11:1990;205-214.
7. Florence A.T. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm. Res. 14:1997;259-266.
8. Florence A.T., Hillery A.M., Hussain N., Jani P.U. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. J. Drug Target. 3:1995;65-70.
9. Herbst, E.F.G., 1844. Das Lymphgefäßsystem und seine Verrichtungen. Vandenhoeck and Ruprecht, Göttingen, pp. 333-337.
10. Hillery A.M., Jani P.U., Florence A.T. Comparative quantitative study of lymphoid and non-lymphoid uptake of 50 nm polystyrene particles. J. Drug Target. 2:1994;151-154.
11. Hillery A.M., Florence A.T. The effect of adsorbed poloxamer 188 and 407 surfactants on the intestinal uptake of 60 nm polystyrene particles after oral administration in rat. Int. J. Pharm. 132:1996;123-130.
12. Hirsch R. Das Vorkommen von Stärkekörnern. Blut Urin. Exp. Pathol. Ther. 3:1906;390-392.
13. Jani P.U., Florence A.T., McCarthy D.E. Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. Int. J. Pharm. 84:1992;245-252.
14. Jani P.U., McCarthy D.E., Florence A.T. Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral dose. Int. J. Pharm. 86:1992;239-246.
15. Jani P., Halbert G.W., Langridge J., Florence A.T. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol. 41:1989;809-812.
16. Jani P.U., Halbert G.W., Langdrige J., Florence A.T. Nanoparticle uptake by the rat gastrointestinal mucosa: Quantification and particle size dependency. J. Pharm. Pharmacol. 42:1990;821-826.
17. Jani P.U., Noruma T., Yamashita F., Takakura Y., Florence A.T., Hashida M. Biliary excretion of polystyrene microspheres with covalently linked FITC fluorescence after oral and parenteral administration to male wistar rats. J. Drug Target. 4:1997;87-93.
18. Jepson M.A., Simmons N.L., O'Hagan D.T., Hirst B.H. Comparison of poly(DL-lactide-co-glycolyde) and polystyrene microsphere targeting to intestinal M cells. J. Drug Target. 1:1993;245-249.
19. Johnson B.A., Kreuter J., Zografi G. Effects of surfactants and polymers on advancing and receding contact angles. Colloid Surfaces. 17:1986;325-342.
20. Kreuter, 1983. Physicochemical characterization of polyacrylic nanoparticles. Int. J. Pharm. 14, 43-58.
21. Kreuter J. Peroral administration of nanoparticles. Adv. Drug Del. Rev. 7:1991;71-86.
22. Kreuter J., Müller U., Munz K. Quantitative and microautoradiographic study on mouse intestinal distribution of polycyanoacrylate nanoparticles. Int. J. Pharm. 55:1989;39-45.
23. LeFevre M.E., Vanderhoff J.W., Laissue J.A., Joel D.D. Accumulation of 2 mm latex particles in mouse Peyer's patches during chronic latex feeding. Experientia. 34:1978;120-122.
24. LeFevre M.E., Hancock D.C., Joel D.D. Intestinal barrier to large particles in mice. J. Tox. Env. Health. 6:1980;691-704.
25. Leroux J.C., Cozens R., Roesel J.L., Galli B., Kubel F., Doelker E., Gurny R. Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice. J. Pharm. Sci. 84:1995;1387-1391.
26. Löbenberg R., Araujo L., Kreuter J. Body distribution of azidothymidine bound to nanoparticles after oral administration. Eur. J. Pharm. Biopharm. 44:1997;127-132.
27. Maincent P., Devissaguet J.P., Le Verge R., Sado P., Couvreur P. Disposition kinetics and oral bioavailability of vincamine loaded polyalkylcyanoacrylate. J. Pharm. Sci. 75:1986;955-958.
28. Nefzger M., Kreuter J., Voges R., Liehl E., Czok R. Distribution and elimination of polymethyl methacrylate nanoparticles after peroral administration to rats. J. Pharm. Sci. 73:1984;1309-1311.
29. Sanders E., Ashworth C.T. A study of particulate intestinal absorption and hepatocellular uptake. Use polystyrene latex particles. Exp. Cell. Res. 22:1961;137-145.
30. Tröster S.D., Kreuter J. Contact angles of surfactants with a potential to alter the body distribution of colloidal drug carries on poly(methyl methacrylate) surfaces. Int. J. Pharm. 45:1988;91-100.
31. Tröster S.D., Müller U., Kreuter J. Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants. Int. J. Pharm. 61:1990;85-100.
32. Verzár F. Aufsaugung und Ausscheidung von Stärkekörnern. Biochem. Z. 34:1911;86.
33. Volkheimer G. Persorption of particles: physiology and pharmacology. Adv. Pharmacol. Chemother. 14:1977;163-187.
34. Volkheimer G., Schulz F.H. The phenomenon of persorption. Digestion. 1:1968;213-218.